HYMED

Welcome to the Brand page for “HYMED”, which is offered here for Pharmaceutical preparations for the treatment of diabetic, chronic and acute wounds and degenerative diseases, all chronic and acute wounds that are defined as full thickness, below the dermis and epidermis, into the subcutaneous tissue and, at times, into the muscle and tendon, such wounds being classified as surgical, traumatic and chronic; pharmaceutical preparations for treatment of degenerative joint diseases such as osteoarthritis and rheumatoid arthritis, and all related joint diseases; veterinary and human applications, surgical and wound dressings; veterinary and human pharmaceuticals for the treatment of degenerative diseases, oral and injectable nutritional supplements; diabetic antiseptic rinses; medicated animal feed and feed supplements for dogs, cats, and equine; chondroprotective agents, pharmaceutical preparations that protect the cellular structure and cartilage in soft and hard tissue; dental wound dressings, dental restoration compounds, and pharmaceutical preparations for the treatment of dental wounds and dental sores, those used in the treatment of periodontal diseases, dry socket, oral wounds and sores, dental irritation, suture sites and traumatic wounds;.

Its status is currently believed to be active. Its class is unavailable. “HYMED” is believed to be currently owned by “Hymed Group Corporation, The”.